Storyboard

Potential fourth COVID-19 vaccine in US

Biotech company Novavax says its COVID-19 vaccine has shown to be highly effective in clinical trials, which puts it on track to become the fourth vaccine available in the United States.

Potential fourth COVID-19 vaccine in US

Photo: ic-cdn.flipboard.com

Continue to read
9 stories in this Storyboard

Related articles

More stories from Coronavirus (COVID-19)

More stories from COVID-19 Vaccines